[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sympathetic-nervous-structure-injury\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sympathetic-nervous-structure-injury":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100589251","hydroxyephedrine-petct-in-sympathetic-nervous-system-disease-100589251",false,"NCT06951984","Hydroxyephedrine PET\u002FCT in Sympathetic Nervous System Disease","Hydroxyephedrine PET\u002FCT in Sympathetic Nervous System Diseases","Inclusion Criteria:\n\n* (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled HED PET\u002FCT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.\n\nExclusion Criteria:\n\n* (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.",true,"ALL","18 Years","80 Years",{"count":21,"type":22},500,"ESTIMATED","7 Days","OBSERVATIONAL","To evaluate the potential usefulness of 11C\u002F18F-HED positron emission tomography\u002F computed tomography (PET\u002FCT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.",[27,28,29],"Sympathetic Nervous System Diseases","Sympathetic Nervous Structure Injury","Sympathetic Nerve Injury",[31,32,33],"PET\u002FCT","MRI","Hydroxyephedrine","RECRUITING","2025-04-23",{"date":37,"type":38},"2025-04-30","ACTUAL",{"date":40,"type":38},"2013-03-01",{"date":42,"type":22},"2028-03-01",{"name":44,"class":45},"Tianjin Medical University","OTHER"]